5-eapb (1-(benzofuran-5-yl)- N-ethylpropan-2-amine) is an entactogenic amphetamine which is fundamentally identified with 5-MAPB and 5-APB. It may be anticipated to demonstrate comparable impacts to these medications in people, however the pharmacology of 5-eapb stays unstudied starting at 2013.

5-EAPB is comparable in structure to mixes, for example, 5-APB which are asserted to be agonists of the 5-HT2C receptor [1] and additionally a triple monoamine reuptake inhibitors, however 5-EAPB is not recorded for instance in this patent, and it is not yet settled to what degree the movement of 5-EAPB takes after that of 5-APB.

As a N-ethyl subordinate of 5-APB, 5-EAPB falls outside the extent of the Transitory Class Sedate boycott issued by the Home Office on June 10, 2013,[2] and stays uncontrolled in the UK as of November 2013. The ACMD has prompted that 5-EAPB (and other – APBs) are moved to Class B,[3] this will probably come energetically on 10 June 2014.

5-EAPB is recorded in the Fifth Timetable of the Abuse of Medications Act (MDA) and consequently unlawful in Singapore as of May 2015

Three individuals in their 30s were hospitalized after each taking roughly 500 mg of 5-EAPB, one of whom later kicked the bucket in doctor’s facility, while going to Brownstock music celebration in Essex, UK.


Leave a Reply

Your email address will not be published. Required fields are marked *